Dr. Jeremy Rees

Dr Jeremy Rees - Publications 2012-2018

1. Seizure outcomes and survival in adult low-grade glioma over 11 years: living longer and better.
   Solomons MR, Jaunmuktane Z, Weil RS, El-Hassan T, Brandner S, Rees JH.
   Neurooncol Pract. 2020 Mar;7(2):196-201. doi: 10.1093/nop/npz056. Epub 2019 Nov 21.
   PMID: 32206321
2. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.
   Hyare H, Rice L, Thust S, Nachev P, Jha A, Milic M, Brandner S, Rees J.
   Eur J Radiol. 2019 May;114:120-127. doi: 10.1016/j.ejrad.2019.03.003. Epub 2019 Mar 14.
   PMID: 31005161
3. Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
   Thust SC, Hassanein S, Bisdas S, Rees JH, Hyare H, Maynard JA, Brandner S, Tur C, Jäger HR, Yousry TA, Mancini L.
   Eur Radiol. 2018 Sep;28(9):3779-3788. doi: 10.1007/s00330-018-5351-0. Epub 2018 Mar 23.
   PMID: 29572636 Free PMC Article
4. The impact of route of diagnosis on survival in patients with glioblastoma.
   Kosmin M, Solda' F, Wilson E, Kitchen N, Rees J, Fersht N.
   Br J Neurosurg. 2018 Dec;32(6):628-630. doi: 10.1080/02688697.2018.1436693. Epub 2018 Feb 9.
   PMID: 29426231
5. Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.
   Hyare H, Thust S, Rees J.
   Curr Treat Options Neurol. 2017 Mar;19(3):11. doi: 10.1007/s11940-017-0445-6. Review.
   PMID: 28349351
6. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
   Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJB, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R.
   Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27.
   PMID: 27686946 Free PMC Article
7. Acute demyelination following radiotherapy for glioma: a cautionary tale.
   Milic M, Rees JH.
   Pract Neurol. 2017 Jan;17(1):35-38. doi: 10.1136/practneurol-2016-001432. Epub 2016 Sep 9.
   PMID: 27613277
8. Diagnostic delay and survival in high-grade gliomas - evidence of the 'waiting time paradox'?
   Aggarwal A, Herz N, Campbell P, Arkush L, Short S, Rees J.
   Br J Neurosurg. 2015;29(4):520-3. doi: 10.3109/02688697.2015.1012050. Epub 2015 Mar 4.
   PMID: 25738427
9. Temozolomide in low-grade gliomas: living longer and better.
   Rees J.
   J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):359-60. doi: 10.1136/jnnp-2014-308880. Epub 2014 Sep 4. No abstract available.
   PMID: 25189160
10. Updates in the management of high-grade glioma.
    Bradley D, Rees J.
    J Neurol. 2014 Apr;261(4):651-4. doi: 10.1007/s00415-013-7032-x. Epub 2013 Jul 16. Review.
    PMID: 23857040
11. Diagnosis and treatment in neuro-oncology: an oncological perspective.
    Rees JH.
    Br J Radiol. 2011 Dec;84 Spec No 2:S82-9. doi: 10.1259/bjr/18061999. Review.
    PMID: 22433832 Free PMC Article
12. The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas.
    Sanghera P, Rampling R, Haylock B, Jefferies S, McBain C, Rees JH, Soh C, Whittle IR.
    Clin Oncol (R Coll Radiol). 2012 Apr;24(3):216-27. doi: 10.1016/j.clon.2011.06.004. Epub 2011 Jul 23. Review.
    PMID: 21783349
13. Quantitative magnetisation transfer imaging in glioma: preliminary results.
    Tozer DJ, Rees JH, Benton CE, Waldman AD, Jäger HR, Tofts PS.
    NMR Biomed. 2011 Jun;24(5):492-8. doi: 10.1002/nbm.1614. Epub 2010 Oct 19.
    PMID: 20960580
14. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force.
    Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W; European Federation of Neurological Societies.
    Eur J Neurol. 2010 Sep;17(9):1124-33. doi: 10.1111/j.1468-1331.2010.03151.x.
    PMID: 20718851
15. Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient.
    Brasil Caseiras G, Ciccarelli O, Altmann DR, Benton CE, Tozer DJ, Tofts PS, Yousry TA, Rees J, Waldman AD, Jäger HR.
    Radiology. 2009 Nov;253(2):505-12. doi: 10.1148/radiol.2532081623. Epub 2009 Sep 29.
    PMID: 19789244
    
16. Quantitative imaging biomarkers in neuro-oncology.
    Waldman AD, Jackson A, Price SJ, Clark CA, Booth TC, Auer DP, Tofts PS, Collins DJ, Leach MO, Rees JH; National Cancer Research Institute Brain Tumour Imaging Subgroup.
    Nat Rev Clin Oncol. 2009 Aug;6(8):445-54. doi: 10.1038/nrclinonc.2009.92. Epub 2009 Jun 23. Review.
    PMID: 19546864
    
17. Astrocytoma derived short-term cell cultures retain molecular signatures characteristic of the tumour in situ.
    Potter NE, Phipps K, Harkness W, Hayward R, Thompson D, Jacques TS, Harding B, Thomas DG, Rees J, Darling JL, Warr TJ.
    Exp Cell Res. 2009 Oct 1;315(16):2835-46. doi: 10.1016/j.yexcr.2009.06.003. Epub 2009 Jun 10.
    PMID: 19523942
    
18. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting.
    Caseiras GB, Chheang S, Babb J, Rees JH, Pecerrelli N, Tozer DJ, Benton C, Zagzag D, Johnson G, Waldman AD, Jäger HR, Law M.
    Eur J Radiol. 2010 Feb;73(2):215-20. doi: 10.1016/j.ejrad.2008.11.005. Epub 2009 Feb 6.
    PMID: 19201123
19. Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.
    Potter N, Karakoula A, Phipps KP, Harkness W, Hayward R, Thompson DN, Jacques TS, Harding B, Thomas DG, Palmer RW, Rees J, Darling J, Warr TJ.
    Neoplasia. 2008 Aug;10(8):757-72.
    PMID: 18670637 Free PMC Article
20. Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.
    Rees J, Watt H, Jäger HR, Benton C, Tozer D, Tofts P, Waldman A.
    Eur J Radiol. 2009 Oct;72(1):54-64. doi: 10.1016/j.ejrad.2008.06.013. Epub 2008 Jul 15.
    PMID: 18632238
21. Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference?
    Caseiras GB, Thornton JS, Yousry T, Benton C, Rees J, Waldman AD, Jäger HR.
    AJNR Am J Neuroradiol. 2008 Jun;29(6):1140-1. doi: 10.3174/ajnr.A0993. Epub 2008 Apr 3.
    PMID: 18388221 Free Article
22. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR.
    Radiology. 2008 Apr;247(1):170-8. doi: 10.1148/radiol.2471062089.
    PMID: 18372467
    
23. Quantitative analysis of whole-tumor Gd enhancement histograms predicts malignant transformation in low-grade gliomas.
    Tofts PS, Benton CE, Weil RS, Tozer DJ, Altmann DR, Jäger HR, Waldman AD, Rees JH.
    J Magn Reson Imaging. 2007 Jan;25(1):208-14.
    PMID: 17139631
    
24. Apparent diffusion coefficient histograms may predict low-grade glioma subtype.
    Tozer DJ, Jäger HR, Danchaivijitr N, Benton CE, Tofts PS, Rees JH, Waldman AD.
    NMR Biomed. 2007 Feb;20(1):49-57.
    PMID: 16986106
25. Differential chemosensitivity of tumor components in a malignant oligodendroglioma: assessment with diffusion-weighted, perfusion-weighted, and serial volumetric MR imaging.
    Jäger HR, Waldman AD, Benton C, Fox N, Rees J.
    AJNR Am J Neuroradiol. 2005 Feb;26(2):274-8.
    PMID: 15709124 Free Article
26. Low-grade gliomas in adults.
    Rees JH.
    Curr Opin Neurol. 2002 Dec;15(6):657-61. Review.
    PMID: 12447102
27. The use of temozolomide in recurrent malignant gliomas.
    Gaya A, Rees J, Greenstein A, Stebbing J.
    Cancer Treat Rev. 2002 Apr;28(2):115-20. Review.
    PMID: 12297119
28. Tectal plate glioma presenting as generalised myasthenia in an adult.
    Rees J.
    J Neurol. 2001 Jul;248(7):630-1. No abstract available.
    PMID: 11518011
29. Primary diffuse leptomeningeal gliomatosis simulating tuberculous meningitis.
    Rees JH, Balakas N, Agathonikou A, Hain SF, Giovanonni G, Panayiotopoulos CP, Luxsuwong M, Revesz T.
    J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):120-2.
    PMID: 11118261 Free PMC Article
30. High-grade glioma mimicking acute viral encephalitis--three case reports.
    Rees JH, Howard RS.
    Postgrad Med J. 1999 Dec;75(890):727-30.
    PMID: 10567599 Free PMC Article
31. Glioblastoma multiforme: radiologic-pathologic correlation.
    Rees JH, Smirniotopoulos JG, Jones RV, Wong K.
    Radiographics. 1996 Nov;16(6):1413-38; quiz 1462-3.
    PMID: 8946545
32. Application of radioimmunoassay to monitor treatment of human cerebral gliomas with bleomycin entrapped within liposomes.
    Firth GB, Firth M, McKeran RO, Rees J, Walter P, Uttley D, Marks V.
    J Clin Pathol. 1988 Jan;41(1):38-43.
    PMID: 2449466 Free PMC Article
33. Malignant optic nerve gliomas in adults.
    Rudd A, Rees JE, Kennedy P, Weller RO, Blackwood W.
    J Clin Neuroophthalmol. 1985 Dec;5(4):238-43.
    PMID: 3001150

Invited Lectures

• "Imaging of High-Grade and Low-Grade Gliomas", Bristol MRI course, January 2015
• "Paraneoplastic Neurological Syndromes", British Neuropsychiatry Association, London, March 2014
• "Management of Epilepsy in Brain Tumours", Key Note Lecture, Epilepsy Masterclass, Cambridge, June 2013
• "New paradigms in glioma imaging: multifunctional MRI" International Symposium on Clinical and Basic Investigation in Glioblastoma, Valencia, June 2011
• "Advances in Management of Low-Grade Gliomas", Association of British Neurologists, Bournemouth, May 2010
• "Integrating MRI decision making in low-grade gliomas: when to stop 'watch and wait'." Trends in CNS malignancies, Budapest, March 2009 "Neurological complications of new chemotherapy & biological agents" European Association of Neuro-oncology, Barcelona, Sept 2008